General Dynamics Unit Must Face $13M Contract Breach Suit
A Maryland federal court allowed a Canadian biotechnology company to proceed with its suit alleging that a General Dynamics subsidiary owes it nearly $13.4 million for developing a nerve agent antidote...To view the full article, register now.
Already a subscriber? Click here to view full article